论文部分内容阅读
探讨降纤酶联合羟乙基淀粉治疗非心源性短暂性脑缺血发作(TIA)的临床效果。选取我院收治的TIA患者50例,随机分为试验组和对照组,对照组给予常规治疗,试验组在常规治疗基础上加用降纤酶联合羟乙基淀粉治疗,观察两组疗效。TIA终止小于1d者观察组14例,对照组10例,两组疗效比较,差异有显著性(P<0.05)。治疗后试验组与对照组在凝血指标PT、APTT和FBG比较,差异有统计学意义(P<0.05)。两组在治疗过程中均未见明显的药物不良反应。降纤酶联合羟乙基淀粉治疗非心源性短暂性脑缺血发作效果更好,值得应用。
To investigate the clinical effect of defibrase combined with hydroxyethyl starch on non-cardiac transient ischemic attack (TIA). Fifty TIA patients admitted to our hospital were randomly divided into experimental group and control group. The control group was given routine treatment. The experimental group was treated with defibrase plus hydroxyethyl starch on the basis of routine treatment, and the curative effect was observed. 14 cases in observation group with TIA less than 1d and 10 cases in control group showed significant difference (P <0.05). After treatment, the coagulation indexes PT, APTT and FBG in test group and control group were significantly different (P <0.05). Two groups in the course of treatment were no obvious adverse drug reactions. Defibrase combined with hydroxyethyl starch treatment of non-cardiac transient ischemic attack is better, it is worth applying.